Zobrazeno 1 - 10
of 28
pro vyhledávání: '"Sara Terezinha Olalla Saad"'
Autor:
Luiza Francisco Trafane, Vitor Antonio da Costa, Adriana da Silva Santos Duarte, Audrey Basso Zangirolami, José Luiz Proenca‐Modena, Paula deMelo Campos, Samuel deSouza Medina, Sara Terezinha Olalla Saad, Marcelo Addas‐Carvalho, Bruno Deltreggia Benites
Publikováno v:
eJHaem, Vol 2, Iss 3, Pp 478-482 (2021)
Abstract Despite being initially considered at higher risk for severe COVID‐19, sickle cell disease (SCD) patients have mostly presented clinical severity similar to the general population. As their vulnerability to become infected remains uncertai
Externí odkaz:
https://doaj.org/article/c3e829abbc1c4da4a56b5dd93b3735bd
Autor:
Renata Sesti-Costa, Marina Dorigatti Borges, Carolina Lanaro, Dulcinéia Martins de Albuquerque, Sara Terezinha Olalla Saad, Fernando Ferreira Costa
Publikováno v:
Frontiers in Immunology, Vol 11 (2021)
Sickle cell disease (SCD), one of the most common hemoglobinopathies worldwide, is characterized by a chronic inflammatory component, with systemic release of inflammatory cytokines, due to hemolysis and vaso-occlusive processes. Patients with SCD de
Externí odkaz:
https://doaj.org/article/09a63da267c24f1e98272b46ae8e1753
Autor:
João Agostinho Machado-Neto, Paula de Melo Campos, Dulcinéia Martins de Albuquerque, Fernando Ferreira Costa, Irene Lorand-Metze, Sara Terezinha Olalla Saad, Fabiola Traina
Publikováno v:
Revista Brasileira de Hematologia e Hemoterapia, Vol 37, Iss 3, Pp 211-214 (2015)
Externí odkaz:
https://doaj.org/article/b8d0ab85400245d99d7ae56a4b493c64
Autor:
Isa Menezes Lyra, Marilda Souza Gonçalves, Joseffina A. Pellegrinei Braga, Maria de Fátima Gesteira, Maria Helena Carvalho, Sara Terezinha Olalla Saad, Maria Stella Figueiredo, Fernando Ferreira Costa
Publikováno v:
Cadernos de Saúde Pública, Vol 21, Iss 4, Pp 1287-1290 (2005)
This study focused on clinical, hematological, and molecular aspects of sickle cell anemia pediatric patients from two different cites in Brazil. Seventy-one patients from São Paulo and Salvador, aged 3 to 18 years, were evaluated. Hematological ana
Externí odkaz:
https://doaj.org/article/26e7a8c110b44841a5f287b39d80c8b7
Autor:
Bruno Deltreggia Benites, Carolina Costa-Lima, Fernanda Batista Rosa Pinto, Vitor Antonio da Costa, Adriana da Silva Santos Duarte, Audrey Basso Zangirolami, Emerson Clayton Amaro, Fabiana Granja, José Luiz Proenca-Modena, Sara Terezinha Olalla Saad, Marcelo Addas-Carvalho
Publikováno v:
Transfusion and Apheresis Science. 61:103513
Even after two years of the pandemic, a completely effective treatment against SARS-CoV-2 has not yet been established. Considering this fact and the emergence of successive new viral variants, the development of therapies based on natural polyclonal
Autor:
Paula de Melo Campos, Marcelo Addas-Carvalho, Bruno Deltreggia Benites, Luiza Francisco Trafane, Vitor A. Costa, Samuel de Souza Medina, Adriana S. S. Duarte, Audrey Basso Zangirolami, Sara Terezinha Olalla Saad, José Luiz Proença-Módena
Publikováno v:
Ejhaem
Despite being initially considered at higher risk for severe COVID‐19, sickle cell disease (SCD) patients have mostly presented clinical severity similar to the general population. As their vulnerability to become infected remains uncertain, we ass
Autor:
Fernando Ferreira Costa, Dulcineia M. Albuquerque, Carolina Lanaro, Sara Terezinha Olalla Saad, Renata Sesti-Costa, Marina Dorigatti Borges
Publikováno v:
Frontiers in Immunology
Frontiers in Immunology, Vol 11 (2021)
Frontiers in Immunology, Vol 11 (2021)
Sickle cell disease (SCD), one of the most common hemoglobinopathies worldwide, is characterized by a chronic inflammatory component, with systemic release of inflammatory cytokines, due to hemolysis and vaso-occlusive processes. Patients with SCD de
Autor:
Fernando Ferreira Costa, João Agostinho Machado-Neto, Patricia Favaro, Renata Scopim-Ribeiro, Mariana Lazarini, Paula de Melo Campos, Irene Lorand-Metze, Sara Terezinha Olalla Saad, Fabiola Traina
Publikováno v:
Applied Cancer Research, Vol 37, Iss 1, Pp 1-7 (2017)
Repositório Institucional da USP (Biblioteca Digital da Produção Intelectual)
Universidade de São Paulo (USP)
instacron:USP
Repositório Institucional da USP (Biblioteca Digital da Produção Intelectual)
Universidade de São Paulo (USP)
instacron:USP
SIVA is a transcriptional target of p53 that plays a potential role in the development and progression of cancer. In this study, we analyzed SIVA1 and SIVA2 expression, and its association with clinical features and TP53 and MDM2 expression in bone m
Autor:
Paolla Ravida Alves de Macedo, Laís Quinteiro Tobaldini, Fernanda Andrade Orsi, Sara Terezinha Olalla Saad, Simone Cristina Olenscki Gilli, Bruno Deltreggia Benites, P.V. Bottini, Celia Regina Garlipp
Publikováno v:
Anais do Congresso de Iniciação Científica da Unicamp.
Autor:
Kleber Yotsumoto Fertrin, Betania Lucena Domingues Hatzlhofer, Aderson S Araujo, Dulcineia M. Albuquerque, Sara Terezinha Olalla Saad, Marcos André Cavalcanti Bezerra, Carolina Lanaro, Carla F. Franco-Penteado, Flavia Rubia Pallis, Mark Westerman, Mariana R. B. Mello, Fernando Ferreira Costa, Gordana Olbina
Publikováno v:
American Journal of Hematology. 89:385-390
Growth differentiation factor 15 (GDF-15) is a bone marrow-derived cytokine whose ability to suppress iron regulator hepcidin in vitro and increased concentrations found in patients with ineffective erythropoiesis (IE)suggest that hepcidin deficiency